The association of polypharmacy with COVID-19 outcomes independent of comorbidities in people with type 2 diabetes: implications for the unforeseen consequences of polypharmacy

Gupta, Juhi K, Ravindrarajah, Rathi, Tilston, George, Ollier, Wiliam ORCID: https://orcid.org/0000-0001-6502-6584, Ashcroft, Darren M and Heald, Adrian H (2024) The association of polypharmacy with COVID-19 outcomes independent of comorbidities in people with type 2 diabetes: implications for the unforeseen consequences of polypharmacy. Cardiovascular Endocrinology & Metabolism, 13 (2). e0304. ISSN 2574-0954

Preview

Published Version
Available under License Creative Commons Attribution.
Download (386kB) | Preview

Item Type:	Article (Article)
Peer-reviewed:	Yes
Date Deposited:	25 Jun 2024 10:38
Publisher:	Ovid Technologies (Wolters Kluwer Health)
Additional Information:	This is an open access article which first appeared in Cardiovascular Endocrinology & Metabolism
Divisions:	Faculties > Science and Engineering
Data Access Statement:	The datasets generated during and analysed during the current study are not publicly available as all data access is subject to review by Health Innovation Manchester.
URI:	https://e-space.mmu.ac.uk/id/eprint/634952
DOI:	https://doi.org/10.1097/xce.0000000000000304
ISSN	2574-0954
e-ISSN	2574-0954

Activity Overview

6 month trend

8Downloads

6 month trend

19Hits

Additional statistics for this dataset are available via IRStats2.

Edit record